
Results
10
Stocks where the price continues to rise after more than a year of consistent gains.
10 companies
TransMedics Group
Market Cap: US$4.5b
A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
TMDX
US$140.21
7D
23.6%
1Y
78.4%
PACS Group
Market Cap: US$4.3b
Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.
PACS
US$29.96
7D
90.8%
1Y
84.7%
GeneDx Holdings
Market Cap: US$4.2b
A genomics company, provides genetic testing services.
WGS
US$161.08
7D
24.3%
1Y
100.2%
Axogen
Market Cap: US$1.2b
Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.
AXGN
US$28.39
7D
20.4%
1Y
110.8%
Nutex Health
Market Cap: US$968.3m
Operates as a healthcare services and operations company in the United States.
NUTX
US$137.21
7D
32.0%
1Y
301.0%
Butterfly Network
Market Cap: US$669.4m
Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
BFLY
US$3.28
7D
66.5%
1Y
0%
NeuroPace
Market Cap: US$478.0m
Operates as a medical device company in the United States.
NPCE
US$16.26
7D
25.6%
1Y
52.5%
SOPHiA GENETICS
Market Cap: US$308.0m
Operates as a cloud-native software technology company in the healthcare space.
SOPH
US$4.86
7D
20.0%
1Y
54.3%
QHSLab
Market Cap: US$3.1m
A medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures.
USAQ
US$0.27
7D
64.9%
1Y
170.0%
VirExit Technologies
Market Cap: US$1.4m
Develops and provides antiviral technologies, personal protective equipment, and health and wellness products.
VXIT
US$0.0005
7D
25.0%
1Y
5.3%